Cellebrite DI (CLBT) Total Non-Current Liabilities (2020 - 2025)

Cellebrite DI's Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $84.9 million for Q4 2025.

• In Q4 2025, Total Non-Current Liabilities rose 43.75% year-over-year to $84.9 million; the TTM figure through Dec 2025 stood at $84.9 million (up 43.75% YoY), while the FY2025 annual figure was $84.9 million, up 43.75% from the prior year.
• Total Non-Current Liabilities was $84.9 million for Q4 2025 at Cellebrite DI, up from $69.7 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $359.5 million in Q2 2024 to a low of $41.4 million in Q3 2021.
• Historically, Total Non-Current Liabilities has averaged $149.8 million across 5 years, with a median of $124.8 million in 2022.
• The sharpest annual moves came in 2021 and 2025: Total Non-Current Liabilities jumped 466.45% in 2021, then plunged 81.76% in 2025.
• A 5-year view of Total Non-Current Liabilities shows it stood at $226.6 million in 2021, then plunged by 46.3% to $121.7 million in 2022, then jumped by 101.27% to $244.8 million in 2023, then plunged by 75.89% to $59.0 million in 2024, then soared by 43.75% to $84.9 million in 2025.
• The last three Total Non-Current Liabilities figures came in at $84.9 million (Q4 2025), $69.7 million (Q3 2025), and $69.0 million (Q2 2025), per Business Quant data.